Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8651-8700 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05150210
SP Thoracic IDE Study
NAActive, not recruiting
32 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
4 conditions1 sponsor6 locations
NCT06029517
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
NAActive, not recruiting
48 participants
Started: Jul 20, 2022 · Completed: Sep 15, 2026
4 conditions2 sponsors1 location
NCT05382299
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
PHASE3Active, not recruiting
623 participants
Started: Jul 20, 2022 · Completed: Jul 31, 2028
2 conditions1 sponsor363 locations
NCT07210879
Early Predictors for Neurological Outcome After Traumatic Spinal Cord Injury
N/AActive, not recruiting
800 participants
Started: Jul 20, 2022 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT06197880
Airway Morphology After En-masse Retraction in Bimaxillary Protrusion Patients
NAActive, not recruiting
20 participants
Started: Jul 20, 2022 · Completed: Feb 1, 2024
1 condition1 sponsor1 location
NCT05334329
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
PHASE1Active, not recruiting
6 participants
Started: Jul 20, 2022 · Completed: Jun 14, 2026
11 conditions2 sponsors1 location
NCT07150091
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 19, 2022 · Completed: Mar 11, 2027
1 condition1 sponsor12 locations
NCT05139004
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
PHASE1Active, not recruiting
7 participants
Started: Jul 19, 2022 · Completed: Jun 13, 2027
4 conditions2 sponsors1 location
NCT05233878
Prognostic's Factors of Head and Neck Paragangliomas Evolution
N/AActive, not recruiting
25 participants
Started: Jul 19, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06512376
Hereditary Cerebral Small Vessel Diseases Registry-Trial Ready Cohort
N/AActive, not recruiting
100 participants
Started: Jul 19, 2022 · Completed: Jul 19, 2027
2 conditions1 sponsor1 location
NCT07051408
Predictors Of Cognitive Decline Using Digital Devices
N/AActive, not recruiting
135 participants
Started: Jul 19, 2022 · Completed: Oct 31, 2025
5 conditions2 sponsors1 location
NCT05670782
A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
PHASE2Active, not recruiting
314 participants
Started: Jul 19, 2022 · Completed: Nov 13, 2025
1 condition2 sponsors3 locations
NCT05396287
Blood Vessel Anatomy and Blood Flow Regulation
N/AActive, not recruiting
80 participants
Started: Jul 19, 2022 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT05308446
Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation
PHASE2Active, not recruiting
84 participants
Started: Jul 19, 2022 · Completed: Feb 28, 2026
8 conditions1 sponsor286 locations
NCT05222555
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
PHASE1/PHASE2Active, not recruiting
53 participants
Started: Jul 19, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor62 locations
NCT05515809
Evaluation of the Effect of Para-sternal Block on Postoperative Respiratory Function After Cardiac Sternotomy Surgery
PHASE3Active, not recruiting
84 participants
Started: Jul 19, 2022 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT05012813
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
NAActive, not recruiting
30 participants
Started: Jul 19, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05241275
Xenon MRI and Progressive ILD
PHASE2Active, not recruiting
60 participants
Started: Jul 19, 2022 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT05867368
Hand-Arm Bimanual Intensive Therapy in Virtual Reality Versus Standard Hand-Arm Bimanual Intensive Therapy
NAActive, not recruiting
17 participants
Started: Jul 18, 2022 · Completed: Sep 21, 2026
1 condition1 sponsor1 location
NCT05406362
Assess Safety and Efficacy of VAD044 in HHT Patients
PHASE1/PHASE2Active, not recruiting
75 participants
Started: Jul 18, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05455294
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
PHASE1Active, not recruiting
16 participants
Started: Jul 18, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors3 locations
NCT05515653
Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population
N/AActive, not recruiting
3,974 participants
Started: Jul 18, 2022 · Completed: Jul 15, 2024
5 conditions3 sponsors41 locations
NCT05104632
Financial Toxicity in Breast Cancer Surgery
N/AActive, not recruiting
630 participants
Started: Jul 18, 2022 · Completed: Feb 1, 2027
1 condition3 sponsors2 locations
NCT05296798
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)
PHASE3Active, not recruiting
922 participants
Started: Jul 18, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor209 locations
NCT06748846
Segmental Muscle Vibration on Pain in Patients With Primary Cervical Dystonia
NAActive, not recruiting
28 participants
Started: Jul 18, 2022 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT05181722
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic
NAActive, not recruiting
196 participants
Started: Jul 18, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05471544
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan
PHASE3Active, not recruiting
3,575 participants
Started: Jul 18, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05385484
A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors
NAActive, not recruiting
1,500 participants
Started: Jul 18, 2022 · Completed: Mar 31, 2026
5 conditions6 sponsors1 location
NCT05438927
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
NAActive, not recruiting
50 participants
Started: Jul 15, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05340270
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2Active, not recruiting
146 participants
Started: Jul 15, 2022 · Completed: Mar 29, 2026
3 conditions10 sponsors1 location
NCT05318066
Effect of a FLUid Bolus or a Low Dose VAsopressor Infusion on Cardiovascular Collapse Among Critically Ill Adults Undergoing Tracheal Intubation.
NAActive, not recruiting
200 participants
Started: Jul 15, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05438940
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
NAActive, not recruiting
23 participants
Started: Jul 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05506254
Long-term Follow-up Study of Patients Who Received hLB-001 Gene Therapy
N/AActive, not recruiting
4 participants
Started: Jul 15, 2022 · Completed: Jan 1, 2037
1 condition1 sponsor4 locations
NCT05126030
The TRICURE First in Human Trial
NAActive, not recruiting
20 participants
Started: Jul 15, 2022 · Completed: May 15, 2029
1 condition1 sponsor11 locations
NCT05301036
Personalized Ultrasonic Brain Stimulation for Depression
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Jul 15, 2022 · Completed: Dec 14, 2024
1 condition1 sponsor1 location
NCT05469568
Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis
NAActive, not recruiting
50 participants
Started: Jul 15, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05474391
MammaPrint Value for Pre-menopausal Breast Cancer Patients
N/AActive, not recruiting
200 participants
Started: Jul 15, 2022 · Completed: Jul 15, 2024
1 condition1 sponsor1 location
NCT05478954
Chemoprevention Efficacy Study in Burkina Faso
PHASE4Active, not recruiting
800 participants
Started: Jul 15, 2022 · Completed: Dec 1, 2023
1 condition1 sponsor1 location
NCT05469503
Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure
NAActive, not recruiting
410 participants
Started: Jul 15, 2022 · Completed: Dec 1, 2024
4 conditions2 sponsors10 locations
NCT04511416
Preventing Cognitive Decline with Metformin
PHASE3Active, not recruiting
242 participants
Started: Jul 15, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05485415
Intervention Study in Elderly With Sleep Problems
NAActive, not recruiting
66 participants
Started: Jul 15, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05411536
Attentional Focus Instructions and Conscious Movement Processing in Older Adults
N/AActive, not recruiting
106 participants
Started: Jul 15, 2022 · Completed: Jun 30, 2024
3 conditions1 sponsor1 location
NCT05406401
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
PHASE2Active, not recruiting
60 participants
Started: Jul 14, 2022 · Completed: Apr 26, 2029
1 condition1 sponsor22 locations
NCT05056623
Effectiveness of a Dyadic Pain Management Program for Community-dwelling Older Adults with Chronic Pain
NAActive, not recruiting
150 participants
Started: Jul 14, 2022 · Completed: Dec 1, 2024
4 conditions5 sponsors1 location
NCT05469009
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
EARLY_PHASE1Active, not recruiting
15 participants
Started: Jul 14, 2022 · Completed: Jul 31, 2029
2 conditions2 sponsors1 location
NCT05340374
Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
35 participants
Started: Jul 14, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT05970757
Physiological MRI for Precision Radiotherapy IDH-wildtype Glioblastoma
NAActive, not recruiting
10 participants
Started: Jul 14, 2022 · Completed: Dec 15, 2025
1 condition1 sponsor1 location
NCT07008924
Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study
N/AActive, not recruiting
50 participants
Started: Jul 14, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05472688
My Baby Biome: Infant Stool Samples for Microbiome Health (MBB)
N/AActive, not recruiting
430 participants
Started: Jul 14, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05404880
INSPIRIS China PMCF Study
N/AActive, not recruiting
255 participants
Started: Jul 13, 2022 · Completed: Dec 31, 2029
1 condition4 sponsors13 locations